A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Preparing Organoids from Tumors: A 3D In Vitro Tumor Model

3.7K views

April 30th, 2023

In This Article

Abstract

Source: Wadosky, K. M., et al. Generation of Tumor Organoids from Genetically Engineered Mouse Models of Prostate Cancer. J. Vis. Exp. (2019).

Organoids derived from tumors are a type of 3D cell culture model that can maintain the pathological features and organ-specific cell lineage of tumors. In the example protocol, we will see scientists generate organoids from a prostate tumor from a genetically engineered mouse model.

Protocol

Animal procedures described here were performed with the approval of the Institutional Animal Care and Use Committee (IACUC) at the Department of Laboratory Animal Resources, Roswell Park Comprehensive Cancer Center, Buffalo, New York.

NOTE: Male mice to be dissected to isolate prostates or prostate tumors for generation of organoids should have at least reached the age of sexual maturity — about 8-10 weeks of age. Specific ages of mice can vary amongst studies. Some factors to consider when choosing age include age-dependent changes in prostate cell populations, age-dependent expression of specific promo....

Access restricted. Please log in or start a trial to view this content.

Results

Prostate tumor preparation flowchart; dissection, enzymatic digestion, cell plating process.
Figure 1: Flow chart of the protocol for generating prostate tumor organoids. After dissecting the prostate tumor, mince the tissue into 1 mm pieces. Digest the tumor pieces in collagenase, collect the cells, and digest in trypsin to obtain a single cell suspension.......

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
0.25% Trypsin+2.21 mM EDTASigma25-053
A83-01MedChemExpressHY-10432
Advanced DMEM/F12+++Gibco12634
Analytical balanceMettler Toledo30216623
B27 (50x)Gibco17504044
Collagenase IIGibco17101015
EHS Sarcoma matrix, Pathclear Lot#19814A10Manufactured by TrevigenRequistitioned from the National Cancer Institute at the Frederick National LaboratoryHolder of grants from the National Cancer Institute can request matrix
HEPES (1 M)Sigma25-060
human recombinant Epidermal growth factor (EGF)PeproTechAF-100-15
L-glutamine (200 mM)Sigma25-005
N-Acetyl-L-CysteineSigmaA9165
Penicillin-StreptomycinSigmaP4333
Precision balanceMettler Toledo30216561
Single-edge carbon razor bladeFisherbrand12-640
Y-276632 (Rock Inhibitor)APExBIOA3008

Tags

Tumor Organoids3D Cell CultureTumor Tissue DigestionCollagenase TreatmentTrypsin DigestionROCK InhibitorMatrix Dome PlatingProstate Cancer ModelGenetically Engineered MouseOrganoid Culture Medium